共 42 条
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
被引:245
作者:
Ma, Lei
[1
]
Seager, Matthew
[1
]
Wittmann, Marion
[1
]
Jacobson, Marlene
[5
]
Bickel, Denise
[1
]
Burno, Maryann
[1
]
Jones, Keith
[1
]
Graufelds, Valerie Kuzmick
[1
]
Xu, Guangping
[1
]
Pearson, Michelle
[1
]
McCampbell, Alexander
[1
]
Gaspar, Renee
[2
]
Shughrue, Paul
[2
]
Danziger, Andrew
[2
]
Regan, Christopher
[2
]
Flick, Rose
[5
]
Pascarella, Danette
[5
]
Garson, Susan
[3
]
Doran, Scott
[3
]
Kreatsoulas, Constantine
[4
]
Veng, Lone
[2
]
Lindsley, Craig W.
[4
]
Shipe, William
[4
]
Kuduk, Scott
[4
]
Sur, Cyrille
[6
]
Kinney, Gene
[2
]
Seabrook, Guy R.
[1
]
Ray, William J.
[1
]
机构:
[1] Alzheimers Res, West Point, PA 19486 USA
[2] Integrat Syst Neurosci, West Point, PA 19486 USA
[3] Depress & Circadian Disorders, West Point, PA 19486 USA
[4] Med Chem, West Point, PA 19486 USA
[5] Schizophrenia Res, West Point, PA 19486 USA
[6] Imaging Merck Res Labs, West Point, PA 19486 USA
来源:
关键词:
PROTEIN-COUPLED RECEPTORS;
SIGNAL-TRANSDUCTION;
ALZHEIMERS-DISEASE;
SEIZURE ACTIVITY;
HIPPOCAMPUS;
EXPRESSION;
SUBTYPES;
MICE;
GENE;
FEAR;
D O I:
10.1073/pnas.0900903106
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
The forebrain cholinergic system promotes higher brain function in part by signaling through the M-1 muscarinic acetylcholine receptor (mAChR). During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M-1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses associated with non-selective muscarinic agonists. We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M-1 mAChR. BQCA reduces the concentration of ACh required to activate M-1 up to 129-fold with an inflection point value of 845 nM. No potentiation, agonism, or antagonism activity on other mAChRs is observed up to 100 mu M. Furthermore studies in M-1(-/-) mice demonstrates that BQCA requires M-1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain. Radioligand-binding assays, molecular modeling, and site-directed mutagenesis experiments indicate that BQCA acts at an allosteric site involving residues Y179 and W400. BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep. In contrast to M-1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces beta-arrestin recruitment to M-1, suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory. In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M-1 receptor and represents a promising therapeutic strategy for cognitive disorders.
引用
收藏
页码:15950 / 15955
页数:6
相关论文